Eton Pharmaceuticals, Inc.(ETON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ETON Eton Pharmaceuticals, Inc.

Post-Mkt 07-10 18:41:39 EDT

36.61

-0.72

-1.93%

盘后36.61

+0.000.00%

16:12 EDT

High37.30	Low35.22	Vol250.80K
Open37.30	D1 Closing37.33	Amplitude5.57%
Mkt Cap998.89M	Tradable Cap870.06M	Total Shares27.28M
T/O9.10M	T/O Rate1.06%	Tradable Shares23.77M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ETON","market":"US","secType":"STK","nameCN":"Eton Pharmaceuticals, Inc.","latestPrice":36.61,"timestamp":1783713600000,"preClose":37.33,"halted":0,"volume":250795,"hourTrading":{"tag":"盘后","latestPrice":36.61,"preClose":36.61,"latestTime":"16:12 EDT","volume":3732,"amount":136628.52,"timestamp":1783714361934,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.019287436378248028,"floatShares":23765564,"shares":27284491,"eps":-0.054613,"marketStatus":"Post-Mkt","change":-0.72,"latestTime":"07-10 18:41:39 EDT","open":37.3,"high":37.3,"low":35.22,"amount":9102657,"amplitude":0.055719,"askPrice":37.32,"askSize":53,"bidPrice":35.96,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-0.054613,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1783728000000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1541739600000,"exchange":"NASDAQ","adjPreClose":37.33,"preHourTrading":{"tag":"盘前","latestPrice":37.24,"preClose":37.33,"latestTime":"09:29 EDT","volume":132,"amount":4922.180472,"timestamp":1783690199999,"change":-0.09,"changeRate":-0.002411,"amplitude":0.006965},"postHourTrading":{"tag":"盘后","latestPrice":36.61,"preClose":36.61,"latestTime":"16:12 EDT","volume":3732,"amount":136628.52,"timestamp":1783714361934,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.616996,"impliedVol":0.574,"impliedVolPercentile":0.2789},"requestUrl":"/m/hq/s/ETON","defaultTab":"news","newsList":[{"id":"2649953531","title":"Opaleye Management Sells 126,685 Eton Pharma Shares for $4.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2649953531","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649953531?lang=en_us&edition=fundamental","pubTime":"2026-07-08 06:30","pubTimestamp":1783463422,"startTime":"0","endTime":"0","summary":"Opaleye Management sells 126,685 Eton Pharma shares for $4.8 millionOpaleye Management, a 10% owner of Eton Pharmaceuticals [ETON], disclosed sales totaling 126,685 common shares from July 2-7.Shares ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDL2j3NY6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Opaleye Management Sells 126,685 Eton Pharma Shares for $4.8 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649623793","title":"Analysts Offer Insights on Healthcare Companies: Eton Pharmaceuticals (ETON), Tarsus Pharmaceuticals (TARS) and Arrowhead Pharmaceuticals (ARWR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2649623793","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649623793?lang=en_us&edition=fundamental","pubTime":"2026-07-06 18:40","pubTimestamp":1783334416,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Eton Pharmaceuticals (ETON), Tarsus Pharmaceuticals ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eton-pharmaceuticals-eton-tarsus-pharmaceuticals-tars-and-arrowhead-pharmaceuticals-arwr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eton-pharmaceuticals-eton-tarsus-pharmaceuticals-tars-and-arrowhead-pharmaceuticals-arwr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LU0128526141.USD","HCSG","XBI","TARS","ARWR","BK4007","ETON","BK4585","LU0029874061.USD","BK4139","BK4588","BK4137","BK4581","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646437364","title":"Analysts’ Top Healthcare Picks: Eton Pharmaceuticals (ETON), Arrowhead Pharmaceuticals (ARWR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2646437364","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646437364?lang=en_us&edition=fundamental","pubTime":"2026-06-27 01:40","pubTimestamp":1782495613,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Eton Pharmaceuticals (ETON) and Arrowhead Pharmaceut...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-eton-pharmaceuticals-eton-arrowhead-pharmaceuticals-arwr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-eton-pharmaceuticals-eton-arrowhead-pharmaceuticals-arwr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","LU0029874061.USD","LU0128526141.USD","HCSG","BK4137","BK4581","BK4585","ARWR","BK4588","BK4007","LABU","XLV","ETON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644724162","title":"Eton Pharma director Jennifer McKie Adams disposes of 50,000 common shares for $1.62 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2644724162","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644724162?lang=en_us&edition=fundamental","pubTime":"2026-06-18 05:08","pubTimestamp":1781730524,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals director Jennifer McKie Adams exercised employee stock options for 50,000 common shares on June 17, 2026 at USD 3.78.Adams sold 50,000 common shares the same day at a weighted average price of USD 32.48.Her direct ownership in the shares reported fell to zero following the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eton Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 17, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nNDL50Hrmv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Eton Pharma director Jennifer McKie Adams disposes of 50,000 common shares for $1.62 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642049714","title":"Eton Pharmaceuticals shareholders elect two directors at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2642049714","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642049714?lang=en_us&edition=fundamental","pubTime":"2026-06-10 04:32","pubTimestamp":1781037178,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals held its annual shareholder meeting on June 9, 2026.Shareholders elected director nominees Jenn Adams, Charles J. Casamento.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eton Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 09, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nNDL8641S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640996473","title":"Eton Pharma CFO Judith Matthews files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2640996473","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640996473?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:27","pubTimestamp":1780345657,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals CFO Judith M. Matthews filed an initial ownership report disclosing 37,000 employee stock options priced at $26.05.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eton Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 01, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDLb0YcSz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639720456","title":"Eton Pharma CEO Sean Brynjelsen sells common shares worth $3.87 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2639720456","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639720456?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:18","pubTimestamp":1780085915,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals President and CEO Sean Brynjelsen sold 120,000 common shares on May 28, 2026.Stock was sold at $31.88 to $32.67 per share.Brynjelsen’s direct holdings fell to 833,694 common shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eton Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL9GbcKw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Eton Pharma CEO Sean Brynjelsen sells common shares worth $3.87 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638634536","title":"Eton Pharma Chief Business Officer David Krempa disposes of 99,999 common shares worth USD 3.24 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2638634536","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638634536?lang=en_us&edition=fundamental","pubTime":"2026-05-28 06:29","pubTimestamp":1779920952,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals Chief Business Officer David Krempa reported option exercises and share sales in late May.Krempa exercised employee stock options for 87,794 shares at USD 1.37–USD 3.58 on May 22–27.He sold 100,000 shares at weighted-average prices of about USD 31.47–USD 35 over May 22–27.His direct common stock holdings fell to 25,249 shares following the transactions.His remaining employee stock options totaled 118,406 shares after the reported exercises.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eton Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 27, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDLbCHyw2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Eton Pharma Chief Business Officer David Krempa disposes of 99,999 common shares worth USD 3.24 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637531453","title":"Analysts Are Bullish on These Healthcare Stocks: Personalis (PSNL), Eton Pharmaceuticals (ETON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637531453","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637531453?lang=en_us&edition=fundamental","pubTime":"2026-05-22 00:50","pubTimestamp":1779382215,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Personalis (PSNL), Eton Pharmaceuticals (ETON) and S...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-personalis-psnl-eton-pharmaceuticals-eton-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-personalis-psnl-eton-pharmaceuticals-eton-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LU0128526141.USD","ETON","PSNL","BLSX","BK4585","BK4121","BK4588","BLSG","LU0029874061.USD","XBI","BK4137","BK4112","BK4581","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636864214","title":"Eton Pharmaceuticals secures US commercialization rights to leishmaniasis drug Impavido","url":"https://stock-news.laohu8.com/highlight/detail?id=2636864214","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636864214?lang=en_us&edition=fundamental","pubTime":"2026-05-20 04:30","pubTimestamp":1779222645,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals signed a supply and distribution agreement to secure exclusive U.S. commercialization rights to IMPAVIDO  from a Knight Therapeutics affiliate.The exclusive rights take effect Sept. 26, 2026, adding another planned 2026 product launch to Eton’s rare disease portfolio.IMPAVIDO is the only FDA-approved oral therapy for certain forms of leishmaniasis, a rare parasitic disease that can be life-threatening if untreated.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDLbgqKXQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SG9999014021.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","NDAQ","LU2095319765.USD","IE00B3QW5Z07.USD","SG9999014013.SGD","BK4585","SG9999014039.USD","IE00BN0W2V16.EUR","LU2210150020.SGD","IE00BN0W2T93.GBP","ETON","SG9999014005.SGD","IE00BGHQF748.EUR","BK4588","LU0314104364.USD","BK4112","IE00BN0W2W23.USD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636235864","title":"Eton Pharmaceuticals Inc - Exclusive U.S. Commercialization Rights to Impavido Effective September 26, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2636235864","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636235864?lang=en_us&edition=fundamental","pubTime":"2026-05-20 04:30","pubTimestamp":1779222600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nTUA64V3VF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636186448","title":"Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to Impavido® (Miltefosine)","url":"https://stock-news.laohu8.com/highlight/detail?id=2636186448","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636186448?lang=en_us&edition=fundamental","pubTime":"2026-05-20 04:30","pubTimestamp":1779222600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nTUA64V3VF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635036464","title":"Eton Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2635036464","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635036464?lang=en_us&edition=fundamental","pubTime":"2026-05-16 00:04","pubTimestamp":1778861040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ETON/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 15, 2026 12:04 ET (16:04 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635080069","title":"Eton Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $57 From $52","url":"https://stock-news.laohu8.com/highlight/detail?id=2635080069","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635080069?lang=en_us&edition=fundamental","pubTime":"2026-05-15 21:54","pubTimestamp":1778853262,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nAZN4SWIP0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635872418","title":"Eton Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2635872418","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635872418?lang=en_us&edition=fundamental","pubTime":"2026-05-15 06:29","pubTimestamp":1778797795,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings SummaryEton Pharmaceuticals Inc ETON.OQ reported quarterly adjusted earnings of 5 cents per share for the quarter end","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nL8N41R2O2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635454725","title":"Eton Pharma swings to Q1 FY26 profit of $1.55 million; revenue rises to $24.27 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635454725","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635454725?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:22","pubTimestamp":1778790140,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals posted GAAP net income of USD 1.55 million for quarter ended March 31, 2026, returning to profit from a GAAP net loss a year earlier; revenue rose 40.4% to USD 24.27 million.Gross profit climbed 49.4% to USD 14.74 million, while research and development expense increased 61.5% to USD 1.88 million.General and administrative expense rose 13.9% to USD 10.45 million, primarily on higher FDA fees and higher employee-related costs due to increased headcount.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eton Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission ,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL8TYzjp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635072531","title":"Eton Pharmaceuticals Q1 product sales rise driven by portfolio expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2635072531","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635072531?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:17","pubTimestamp":1778789829,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals Q1 product sales rise driven by portfolio expansionOverviewUS rare disease drugmaker's Q1 product sales grew 73% yr/yr, driven by portfolio expansionCompany raised 2026 revenue gu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nL1N41R1A9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635258137","title":"GUIDANCE: (ETON) Eton Pharmaceuticals Expects 2026 Revenue to Exceed $120M, vs. FactSet Est of $108.4M","url":"https://stock-news.laohu8.com/highlight/detail?id=2635258137","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635258137?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:14","pubTimestamp":1778789669,"startTime":"0","endTime":"0","summary":"GUIDANCE: (ETON) Eton Pharmaceuticals Expects 2026 Revenue to Exceed $120M, vs. FactSet Est of $108.4M","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635072324","title":"Eton Pharmaceuticals Q1 Adj. EPS $0.14 Beats $0.09 Estimate, Sales $24.266M Beat $22.312M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635072324","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635072324?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:09","pubTimestamp":1778789391,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.09 by 55.56 percent. This is a 100 percent increase over earnings of $0.07 per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52580060/eton-pharmaceuticals-q1-adj-eps-0-14-beats-0-09-estimate-sales-24-266m-beat-22-312m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Eton Pharmaceuticals Q1 Adj. EPS $0.14 Beats $0.09 Estimate, Sales $24.266M Beat $22.312M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635965723","title":"BRIEF-Eton Pharmaceuticals Q1 Net Income USD 1.554 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635965723","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635965723?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:05","pubTimestamp":1778789150,"startTime":"0","endTime":"0","summary":"BRIEF-Eton Pharmaceuticals Q1 Net Income USD 1.554 Million\n\n\nMay 14 (Reuters) - Eton Pharmaceuticals Q1 EPS USD 0.05.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nPLX933A07:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.etonpharma.com","stockEarnings":[{"period":"1week","weight":-0.0045},{"period":"1month","weight":0.2227},{"period":"3month","weight":0.4162},{"period":"6month","weight":1.4146},{"period":"1year","weight":1.3672},{"period":"ytd","weight":1.2076}],"compareEarnings":[{"period":"1week","weight":0.0093},{"period":"1month","weight":0.0199},{"period":"3month","weight":0.1063},{"period":"6month","weight":0.083},{"period":"1year","weight":0.2045},{"period":"ytd","weight":0.1023}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.049574},{"month":2,"riseRate":0.5,"avgChangeRate":0.007501},{"month":3,"riseRate":0.5,"avgChangeRate":0.000763},{"month":4,"riseRate":0.375,"avgChangeRate":0.041311},{"month":5,"riseRate":0.625,"avgChangeRate":0.018979},{"month":6,"riseRate":0.25,"avgChangeRate":-0.044284},{"month":7,"riseRate":0.5,"avgChangeRate":-0.02737},{"month":8,"riseRate":0.714286,"avgChangeRate":0.150873},{"month":9,"riseRate":0.571429,"avgChangeRate":0.07288},{"month":10,"riseRate":0.571429,"avgChangeRate":0.067693},{"month":11,"riseRate":0.571429,"avgChangeRate":0.051311},{"month":12,"riseRate":0.625,"avgChangeRate":0.051914}],"exchange":"NASDAQ","name":"Eton Pharmaceuticals, Inc.","nameEN":"Eton Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Eton Pharmaceuticals, Inc.(ETON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Eton Pharmaceuticals, Inc.(ETON) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Eton Pharmaceuticals, Inc.,ETON,Eton Pharmaceuticals, Inc.股票,Eton Pharmaceuticals, Inc.股票老虎,Eton Pharmaceuticals, Inc.股票老虎国际,Eton Pharmaceuticals, Inc.行情,Eton Pharmaceuticals, Inc.股票行情,Eton Pharmaceuticals, Inc.股价,Eton Pharmaceuticals, Inc.股市,Eton Pharmaceuticals, Inc.股票价格,Eton Pharmaceuticals, Inc.股票交易,Eton Pharmaceuticals, Inc.股票购买,Eton Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Eton Pharmaceuticals, Inc.(ETON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Eton Pharmaceuticals, Inc.(ETON) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}